Library
curevc.comCrawled Oct 26, 2026
Product
6 pages- Clasp Therapeutics/curevc-portfolio/clasp-therapeutics
Clasp designs T cell engagers targeting tumor-specific mutations in hard-to-treat cancers.
- Companies/companies
Cure Ventures partners with entrepreneurs like Dr. Milenko Cicmil to advance drug discovery, exemplified by Tasca Therapeutics.
- Curevc Portfolio Archive/curevc-portfolio
Aevum develops exercise-derived therapies for neurodegenerative disorders, including Parkinson’s disease.
- Kenai Therapeutics/curevc-portfolio/kenai-therapeutics
Kenai advances dopamine neuron replacement therapies for neurological disorders like Parkinson’s disease.
Blog
2 pages- Cure Venture News Archives/category/cure-venture-news
- Founder Stories Archives/category/founder-stories
Press
3 pages- Cure Ventures Launches with the Close of Inaugural $350 Million Fund/cure-ventures-launches-with-close-of-inaugural-350-million-dollar-fund
Cure Ventures (“Cure”), a life sciences venture capital firm focusing on company formation around groundbreaking curative technologies, today announced the closing of its inaugural fund, Cure Ventures Fund I, L.P., at its targeted hard-cap of $350 million in capital commitments.
- News/news
Cure Ventures announces Nobel Laureate Gary Ruvkun as keynote speaker for its 2026 Annual General Meeting.
- Nobel Laureate Gary Ruvkun to Keynote Cure Ventures’ 2026 Annual General Meeting/nobel-laureate-gary-ruvkun-to-keynote-cure-ventures-2026-annual-general-meeting
Careers & Hiring
1 page- Careers/careers
Cure Ventures seeks top talent to join its team of entrepreneurs, scientists, and industry veterans in developing therapeutics.
Team
6 pages- Curevc Team Archive/curevc-team
- Dr. Milenko Cicmil’s Story on How Tasca Came to Be/dr-milenko-cicmil-story-how-tasca-came-to-be
- Lou Tartaglia, Ph.D./curevc-team/lou-tartaglia-ph-d
Dr. Tartaglia has over 30 years of experience in biotech scientific leadership and venture capital investment.
- Milenko Cicmil, Ph.D./curevc-team/milenko-cicmil-ph-d
Dr. Cicmil brings 20 years of drug discovery experience, focusing on inflammation, autoimmunity, and oncology.
About
2 pagesContact
1 page- Contact Us/contact-us
Homepage
1 page- Homepage/
Cure Ventures collaborates with entrepreneurs to bring evidence-based cures to life in medicine.
Privacy
1 page- Privacy Policy/privacy-policy
